drugset / Trial / NCT07487766
The Safety and Efficacy of XytriX (Umbilical Cord-Derived Mesenchymal Stem Cells) in the Treatment of Knee Osteoarthritis
RandomizedParallel-groupSingle-blindTreatment
Summary
This study aims to study the safety and efficacy of XytriX, an umbilical cord-derived stem cell product, in the treatment of Grade I-IV knee osteoarthritis.
Timeline
- Start
- 2026-05
- Primary completion
- 2027-05
- Completion
- 2028-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | XytriX | Cell therapy | 10 cells | Other |
| Subject | XytriX | Cell therapy | 30 cells | Other |
| Subject | XytriX | Cell therapy | 50 cells | Other |